Nanochap raises RMB 500 million for vision-restoring brain-computer interfaces
Gaorong Ventures led the Series C+; the Hangzhou company says its 320-channel retinal implant is in clinical trials with three participants, while a 1,280-channel visual-cortex interface is still in development.